BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10823319)

  • 1. PUVA improvements will come from molecular biology.
    Gasparro FP
    Photodermatol Photoimmunol Photomed; 2000 Apr; 16(2):83-4. PubMed ID: 10823319
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 in dermatology.
    Gasparro FP
    Arch Dermatol; 1998 Aug; 134(8):1029-32. PubMed ID: 9722740
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP
    Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
    Lindelöf B
    Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
    J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of the scrotum.
    Taniguchi S; Furukawa M; Kutsuna H; Sowa J; Ishii M
    Dermatology; 1996; 193(3):253-4. PubMed ID: 8944352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoralen and ultraviolet a light therapy for psoriasis.
    Stern RS
    N Engl J Med; 2007 Aug; 357(7):682-90. PubMed ID: 17699818
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug and chemical induced photosensitivity from a clinical perspective.
    Ibbotson S
    Photochem Photobiol Sci; 2018 Dec; 17(12):1885-1903. PubMed ID: 30283959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer induction by immunosuppression in psoriasis after heavy PUVA treatment.
    Molin L; Larkö O
    Acta Derm Venereol; 1997 Sep; 77(5):402. PubMed ID: 9298142
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple eruptive actinic keratoses and squamous cell carcinomata following PUVA therapy of more than 11 years.
    Beiteke U; Budde J; Lentner A; Stary A; Tronnier H
    Photodermatol; 1988 Dec; 5(6):274-6. PubMed ID: 3249686
    [No Abstract]   [Full Text] [Related]  

  • 12. [Puva therapy and carcinogenesis].
    Thomas P; Pannequin C
    Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842
    [No Abstract]   [Full Text] [Related]  

  • 13. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I; Stern RS
    Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current treatment of psoriasis].
    Karvonen J
    Duodecim; 2000; 116(24):2769-75; quiz 2776, 2787. PubMed ID: 12077879
    [No Abstract]   [Full Text] [Related]  

  • 15. PUVA photocarcinogenesis in Cheshire.
    Cockayne SE; August PJ
    Clin Exp Dermatol; 1997 Nov; 22(6):300-1. PubMed ID: 9604461
    [No Abstract]   [Full Text] [Related]  

  • 16. 6-Methylangelicins: new monofunctional photochemotherapeutic agents for psoriasis.
    Cristofolini M; Recchia G; Boi S; Piscioli F; Bordin F; Baccichetti F; Carlassare F; Tamaro M; Pani B; Baburdi N
    Br J Dermatol; 1990 Apr; 122(4):513-24. PubMed ID: 2337519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS; Laird N
    Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.